MiNK Therapeutics, Inc. announced that Jennifer Buell resigned as Agenus Inc.'s, President and Chief Operating Officer to become the President and Chief Executive Officer of the company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.98 USD | +1.16% | -0.51% | -8.41% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.41% | 3.78Cr | |
+52.36% | 5.81TCr | |
-3.86% | 4.05TCr | |
+38.14% | 3.9TCr | |
-12.01% | 2.66TCr | |
+14.13% | 2.67TCr | |
-21.62% | 1.9TCr | |
+0.21% | 1.22TCr | |
+25.96% | 1.19TCr | |
+23.02% | 1.2TCr |
- Stock Market
- Equities
- INKT Stock
- News MiNK Therapeutics, Inc.
- MiNK Therapeutics, Inc. Announces Appointment of Jennifer Buell as Chief Executive Officer